|
|
|
|
|
|
by drdeca
1468 days ago
|
|
|
Proof? The point aiui is mostly arguing that the FDA errs too much on the side of caution in this area, and the trade-off would have been worth it to approve earlier. Not insinuating that like, there was some corruption (or laziness or something) that delayed it. |
|
|